Perceiv AI
Predicting disease progression with AI
- Employees
- 1–10
- Business Model
- B2B
- Website
- perceiv.ai
- Last Round
- SeedDec 2022
- Rounds
- 1
About
Perceiv AI is a Toronto-based artificial intelligence company that uses multimodal data and machine learning to predict disease progression for clinical trials and pharmaceutical drug development. The platform analyzes imaging, biomarker, and clinical data to generate predictive models that help drug developers identify the right patients, design more efficient trials, and reduce attrition. Perceiv AI's technology is particularly focused on neurodegenerative diseases such as Alzheimer's.
Summary
Perceiv AI is a Healthcare company based in Canada. Its most recent funding was a Seed round in Dec 2022. Investors include Plug and Play, Boreal Ventures and IKJ Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2022
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...